Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 8:51 PM

Published 11/04/2009 by PipelineReview


Novartis announces USD 1 billion investment to build largest pharmaceutical R&D ...

* Novartis Institute of BioMedical Research in Shanghai, an integral part of the Novartis global R&D network worldwide, to rank third largest for Novartis worldwide

* Additional USD 250 million invested in advanced technical R&D and manufacturing facility opening in Changshu, furthering...

Share this 

What others report on the same story

Pharma’s Hiring! (In China)
The global drug industry’s long push into China continued today, as Novartis said it plans to spend $1 billion to expand its R&D center in Shanghai. Dow Jones has ... - [11/03/2009 - WSJ.com: Health Blog]
Novartis announce details of $1billion investment
announced today a $1 billion investment over the next five years, increasing R&D activities in China and confirming ' long term commitment to China's further economic ... - [11/03/2009 - Pharmacy Europe]
Novartis To Invest US$1 Bln In China To Build L... - [11/03/2009 - RTTNews.com]
Novartis invests $1B for R&D in China - [11/03/2009 - Philippine Daily Inquirer]
Novartis to invest billion dollars in China - [11/03/2009 - France24 - Business]
Novartis to invest billion dollars in China - [11/03/2009 - France24 - france]
Novartis to invest billion dollars in China - [11/03/2009 - France24 - europe]
Novartis to invest billion dollars in China - [11/03/2009 - France24 - Middle East]
Novartis to invest billion dollars in China - [11/03/2009 - France24 - Africa]
1 2 3 4

Quotes

"We are confident that our expanded investment in R&D will result in innovative therapies for patients in China and other countries nurtured by the growing scientific excellence in China." said Dr Daniel Vasella...
Novartis announces USD 1 billion investment to build largest pharmaceutical R&D ... [PipelineReview - 11/04/2009]
...CEO of Novartis. "We are also pleased to contribute to the Shanghai government's aim to establish the city as the premiere R&D center for China's bio-medicine industry by 2012, as Novartis is committed to investing to further the Chinese government's strategy for stimulating economic growth, stability and enhancing the livelihood of the Chinese people."
Novartis announces USD 1 billion investment to build largest pharmaceutical R&D ... [PipelineReview - 11/04/2009]

Related Stories

First Reported 11/04/2009 - Updated 11/05/2009 - 10 Documents (in Medicine)
Novartis To Expand Its Human Vaccines Presence In China Through Proposed Acquisition Of A Majority Stake In Zhejiang Tianyuan
Tianyuan a privately-held vaccines company providing a competitive product portfolio and pipeline in China, where Novartis has a limited vaccines presenceTianyuan and Novartis to collaborate on building a vaccines industry leader targeting unmet medical ... [Pharmaceutical Online - 11/05/2009]
First Reported 10/29/2009 - Updated 10/30/2009 - 9 Documents (in Health)
Novartis: US vaccine order is on track
Novartis on track to produce 90 million units of bulk antigen in line with commitment to US Department of Health and Human Services, despite very low yields of initial seed virus90 million units of bulk antigen expected to result in 60 million vaccine ... [Pharmaceutical Engineering Innovation - 10/30/2009]
First Reported 11/09/2009 - Updated 11/10/2009 - 8 Documents
Novartis is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical
Hard To Treat Diseases (HTDS.PK) www.htdsmedical.com, announced today that Novartis, a US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for US$125 ... [Mbendi - 11/10/2009]
First Reported 11/05/2009 - Updated 11/06/2009 - 8 Documents
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
South Korea investigates Roche and Novartis
Swiss rival Novartis was also involved in the investigation by the Korea Food and Drug Administration (FDA) into pandemic stockpiling activities by corporations.Roche, based in Basel, confirmed that its South Korean affiliate had been "visited" by the ... [Swiss Info - 11/06/2009]
First Reported 10/29/2009 - Updated 10/30/2009 - 4 Documents
Novartis AG - Click to view image in its original context
Novartis AG
Novartis takes a pass on Idenix drug
Novartis has elected not to exercise its option to license Idenix Pharmaceuticals' IDX184, a potential treatment for hepatitis C. Idenix retains worldwide rights to the drug. 'As we continue to develop IDX184, we look forward to seeking a partner that ... [FierceBiotech - 10/30/2009]
First Reported 10/30/2009 - Updated 10/31/2009 - 3 Documents (in Health)
GlaxoSmithKline plc - Click to view image in its original context
GlaxoSmithKline plc
Switzerland restricts use of GlaxoSmithKline H1N1 flu vaccine
GENEVA: Switzerland on Friday restricted the use of British drugs group GlaxoSmithKline's H1N1 flu vaccine Pandemrix, excluding pregnant women, minors and people over the age of 60.The regulatory authority Swissmedic said it had received data on the vaccine ... [Channel NewsAsia - 10/31/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 3 Documents (in Internet & IT)
Gilead Sciences Inc - Click to view 360-page
Gilead Sciences Inc
Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics
Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4581.Visit http://www.zacks.com/performance for information ... [Earthtimes.org - 11/10/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 12 Documents
China OKs Shanghai Disney theme park ...
China has given the green light for Walt Disney to build its long-awaited first theme park on the mainland in Shanghai, after a decade of negotiations. The announcement of the deal, which would be one of the biggest ever foreign investments in China, ... [Radio Television Hong Kong - 11/04/2009]
First Reported 11/09/2009 - Updated 11/09/2009 - 8 Documents
China car sales surge on stimulus steps
China's passenger cars sales in October surged 75.8% compared with a year earlier, extending the growth in recent months prompted by government incentives ... [FT.com - Companies - 11/09/2009]
Entities: China
First Reported 11/05/2009 - Updated 11/05/2009 - 5 Documents
Disney's China Move: A Big Growth Opportunity for Mickey
You are currently following John DessauerStop FollowingYou are no longer following John DessauerAbout this author:Profile & More ArticlesVisit: John Dessauer InvestmentsFont Size:PrintEmailOn November 4, 2009, Walt Disney Co. (DIS) said Chinese government ... [Seeking Alpha - 11/05/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 4 Documents
China says yes to Disney park in Shanghai
Photo: REUTERS DISNEY plans to sprinkle its magic over mainland China for the first time, with officials announcing today the long-awaited approval of a theme park in the booming metropolis of Shanghai. The green light for the park, which would be one ... [Business Day - 11/04/2009]
First Reported 11/04/2009 - Updated 11/05/2009 - 4 Documents
Disney To Build Shanghai Park
SHANGHAI - The Walt Disney Co's breakthrough deal to build one of its signature theme parks in Shanghai marks a significant advance for Western media and entertainment firms trying to crack a tough China market.Wednesday's government approval for the ... [NewsMax.com - 11/05/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
China Is Growth Market for Novartis [Healthcare Sector and Stocks Analysis from Seek ... - 11/08/2009]
The Burrill Report submits: The Swiss pharmaceutical giant Novartis (NVS) said it will invest $1 billion in China over the next five years including a significant ...
Novartis Seeks to Make China One of Its Top Thr... [Biotech Sector and Stocks Analysis from Seeking ... - 11/04/2009]
ChinaBio Today submits: Novartis (NYSE: NVS) of Switzerland will begin a five-year, $1 billion China initiative with two aims: the company will dramatically increase ...
Novartis Joins Global Interest in Vaccines with... [Biotech Sector and Stocks Analysis from Seeking ... - 11/05/2009]
ChinaBio Today submits: Novartis (NYSE: NVS) continued its mega-investments in China by announcing it will spend $250 million to expand its global technical center ...
Novartis Pays $125 Million for Tianyuan Stake [DealBook - 11/04/2009]
Novartis, the Swiss drug giant, said Wednesday it has agreed to cough up $125 million for an 85 percent stake in Chinese vaccine maker Zhejiang Tianyuan Bio-Ph ...
Week in Review: Major Investments in China Biot... [Biotech Sector and Stocks Analysis from Seeking ... - 11/08/2009]
ChinaBio Today submits: China life science news last week was dominated by stories of substantial foreign investments in China’s pharmaceutical sector. The Swiss ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
How nagging text messages can make you healthie... [Slate Magazine - 11/10/2009]
A Jewish Mother in Your Cell Phone [Slate Magazine - 11/10/2009]
China agrees Disney theme park in Shanghai [ITN News - YouTube - 11/04/2009]
China lifts spirits [Reuters Video: Business - 11/11/2009]
China at 60 [UC Television - YouTube - 10/30/2009]
1 2 3 4 5 6 7 8 9 10 ...

  •  
  •  
  •